Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 23, No 12 (April 20), 2005: pp. 2874-2875
© 2005 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2005.05.338

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, B. D.
Right arrow Articles by Wilson, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, B. D.
Right arrow Articles by Wilson, L. D.
Related Articles
Right arrowRelated Reply
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

CORRESPONDENCE

Do PET and SNB Reduce the Rate of Elective Neck Dissection? A Hypothesis Still in Need of Validation

Benjamin D. Smith, Brian E. Lally, Bruce G. Haffty, Lynn D. Wilson

Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT

To the Editor:

In their recent article, Kovács et al1 report their experience utilizing positron emission tomography (PET), computed tomography (CT), and sentinel node biopsy (SNB) in a prospective cohort of patients with resectable T1-3 squamous cell carcinoma of the oral cavity and oropharynx. This experience represents an important addition to the literature regarding the use of PET in the management of such patients. The authors conclude that a strategy utilizing PET and SNB considerably reduces the number of extensive neck dissections performed when compared with a treatment strategy that relies on only CT. However, the data presented do not necessarily support this conclusion.

For the identification of cervical lymph node metastasis, the authors state that CT "had a clear advantage" regarding sensitivity and that PET "had a clear advantage" regarding specificity. However, because these differences were not statistically significant, it is inappropriate to conclude that either PET or CT is better. In addition, administration of high-dose intra-arterial cisplatin after imaging and before SNB or neck dissection could have sterilized microscopic disease and thus artifactually increased the observed false-positive rates for both CT and PET.

The authors claim that a strategy using SNB for patients who are cN0 by PET will reduce the number of neck dissections required. They begin with the a priori assumption that an ipsilateral level I-V modified radical neck dissection (MRND) is indicated for all patients with suspected cervical lymph node metastasis. Thus, if PET reveals evidence for cervical metastasis, a modified radical neck dissection is performed. If PET reveals no evidence for cervical metastasis, a modified radical neck dissection is performed only if SNB is positive.

The authors state that this strategy markedly reduced the number of neck dissections performed when compared with a CT-based strategy. First, they state in the abstract that 96 of 124 neck sides would have required a neck dissection (either selective or modified radical) on the basis of a CT approach, but only 41 of 124 neck sides actually required dissection with the PET + SNB approach. This statement generates confusion because the CT-based approach assumes that selective neck dissection is performed for all cN0 patients, whereas the PET-based approach assumes that SNB is performed for all cN0 patients. Thus, the authors are comparing two different treatment paradigms, not two different imaging tests.

The real comparison should be the difference in neck dissection rates for a PET + SNB approach versus a CT + SNB approach. With the PET-based approach, 41 neck dissections were performed. The number of neck dissections that would have been performed with a CT + SNB approach is theoretically derived from the observed sensitivity and specificity of CT and is approximately 45, but may be as high as 49. Thus, addition of PET spared only four to eight neck sides from dissection.

Finally, it should be emphasized that the "unnecessary" neck dissections with the CT + SNB strategy are attributed to an excess in false-positive CT results as compared with PET results. However, all of these excess CT false-positive cases were evaluated with only SNB, a technique that may underestimate the true likelihood of cervical metastasis when compared with the gold standard of level I-V neck dissection.2 Thus, the reported CT false-positive rate may be artifactually elevated. If the false-positive rate of CT is truly lower than reported in this study, then the number of "unnecessary" neck dissections would decrease, further narrowing the difference between CT- and PET-based approaches.

In summary, this article supports the hypothesis that excellent outcomes can be achieved using SNB to evaluate the clinically negative neck. However, there appears to be no clinically or statistically significant difference between PET and CT when integrated with SNB in the staging of patients with head and neck cancer.

Authors' Disclosures of Potential Conflicts of Interest

The authors indicated no potential conflicts of interest.

Acknowledgment

The authors whish to acknowledge Dr Gabriel N. Hortobagyi for reviewing this letter.

REFERENCES

1. Kovács AF, Dobert N, Gaa J, et al: Positron emission tomography in combination with sentinel node biopsy reduces the rate of elective neck dissections in the treatment of oral and oropharyngeal cancer. J Clin Oncol 22:3973-3980, 2004[Abstract/Free Full Text]

2. Ross GL, Shoaib T, Soutar DS, et al: The First International Conference on Sentinel Node Biopsy in Mucosal Head and Neck Cancer and adoption of a multicenter trial protocol. Ann Surg Oncol 9:406-410, 2002[CrossRef][Medline]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Reply

  • In Reply:
    Adorján F. Kovács
    JCO 2005 23: 2875-2876 [Full Text]



This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, B. D.
Right arrow Articles by Wilson, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, B. D.
Right arrow Articles by Wilson, L. D.
Related Articles
Right arrowRelated Reply
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2005 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online